Across research and health policy, the unique needs of women as patients, caregivers, and primary health care decision-makers for their families are receiving more attention.
The national opioid epidemic was already raging before COVID-19 hit the United States. During the pandemic, the situation severely worsened, including for those who are pregnant.
SWHR convened an interdisciplinary working group for a closed roundtable meeting to discuss how to eliminate barriers to access and reduce health disparities related to genetic screening, with a focus on noninvasive prenatal screening (NIPS) and expanded carrier screening (ECS).
SWHR convened an interdisciplinary working group for a closed roundtable meeting to discuss how to eliminate barriers to access and reduce health disparities related to genetic screening, with a focus on noninvasive prenatal screening (NIPS) and expanded carrier screening (ECS).
SWHR hosted a virtual congressional briefing to raise awareness of policy needs to improve care for individuals with uterine fibroids, a condition that is underfunded and often overlooked in research.
SWHR convened a working group of basic and clinical researchers, health care providers, patients/patient advocates, and policy leaders for a closed, two-day roundtable meeting to discuss the health, social, and economic impacts of alopecia, atopic dermatitis, and psoriatic arthritis on women.